Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1998 1
1999 5
2000 2
2001 2
2002 4
2003 2
2004 1
2005 4
2006 1
2007 2
2008 2
2009 6
2010 7
2011 3
2012 2
2013 1
2014 3
2015 2
2016 2
2017 5
2018 5
2019 7
2020 3
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Lymphangiogenesis and anti-tumor immune responses.
Varney ML, Singh S, Backora M, Chen Z, Singh RK. Varney ML, et al. Curr Mol Med. 2009 Aug;9(6):694-701. doi: 10.2174/156652409788970733. Curr Mol Med. 2009. PMID: 19689296 Review.
ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.
Bhuiyan NH, Varney ML, Bhattacharya DS, Payne WM, Mohs AM, Holstein SA, Wiemer DF. Bhuiyan NH, et al. Among authors: varney ml. Bioorg Med Chem Lett. 2019 Oct 1;29(19):126633. doi: 10.1016/j.bmcl.2019.126633. Epub 2019 Aug 20. Bioorg Med Chem Lett. 2019. PMID: 31474482 Free PMC article.
Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.
Sharma B, Singh S, Varney ML, Singh RK. Sharma B, et al. Among authors: varney ml. Expert Opin Ther Targets. 2010 Apr;14(4):435-42. doi: 10.1517/14728221003652471. Expert Opin Ther Targets. 2010. PMID: 20230195 Free PMC article. Review.
CXCR2: A Novel Mediator of Mammary Tumor Bone Metastasis.
Sharma B, Nannuru KC, Saxena S, Varney ML, Singh RK. Sharma B, et al. Among authors: varney ml. Int J Mol Sci. 2019 Mar 12;20(5):1237. doi: 10.3390/ijms20051237. Int J Mol Sci. 2019. PMID: 30871004 Free PMC article.
68 results